Essex Bio-Technology Announces 2022 Annual Financial Results
HONG KONG, Mar 8, 2023 – (ACN Newswire) – Essex Bio-Technology Ltd (“Essex” or the…
HONG KONG, Mar 8, 2023 – (ACN Newswire) – Essex Bio-Technology Ltd (“Essex” or the…
DUBAI, Mar 8, 2023 – (ACN Newswire) – KARM Legal Consultants, a leading law firm…
Intentional design will make healthcare technology and efficiency hallmarks of this Paramus, NJ, facility. CANTON,…
New platform is designed to enable VARs and customers to extract maximum control of their…
NEEDHAM, Mass.–(BUSINESS WIRE)–#ARGlasses–The pendulum for AR/VR headsets swung the other way through the course of…
WALTHAM, Mass.–(BUSINESS WIRE)–Ondas Holdings Inc. (Nasdaq: ONDS) (“Ondas” or the “Company”), a leading provider of…
Bioplastics company, in celebration of National Biobased Products Day, encourages wider adoption of similar programs…
Global technology provider and specialist distributor extends Juniper Networks partnership into Benelux, Cyprus, Greece, Italy…
Custom 25-Foot 3D Sidewalk Chalk Art Installation in Downtown Austin Inspired by Fully Immersive Lume…
STALICLA signs Cooperative Research and Development Agreement (CRADA) with US National Institute on Drug Abuse…
CRADA to support investigation of Tessa’s lead allogeneic cell therapy, TT11X, in several subtypes of…
Delivers strong year-over-year growth in revenue, Adjusted EBITDA and profitability Introduces “Elevating Excellence” value creation…
HONG KONG, Mar 8, 2023 – (ACN Newswire) – OrbusNeich Medical Group Holdings Limited (“OrbusNeich”…
HONG KONG, Mar 8, 2023 – (ACN Newswire) – Quamnet Outstanding Enterprise Awards 2022 announced…
Swedish company Epishine announces a partnership with US-based Atmosic Technologies. The combination of Epishine’s indoor…
Organizations in both industries are falling short when addressing new challenges to protect data in…
London, UK – 8 March 2023. The latest Enterprise Software M&A report from Hampleton Partners,…
Sponsor of Gastro Update 2023, 2-day scientific and training events for gastroenterology professionals Patient Education…
Tokyo, Japan and Cambridge, UK, 8 March 2023 – Sosei Group Corporation (“the Company”; TSE:…
Phase 3 aims to demonstrate cardiovascular benefit of Teverelix versus GnRH agonists. Up to 30%…